DEFA14A ·Filed Apr 21, 2026

BMRN

BIOMARIN PHARMACEUTICAL INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001628280-26-026298
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine proxy filing with no immediate financial implications. Monitor for any subsequent filings that may contain material information.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
BMRN ▲ +10.77% at T+60d
NEUTRAL call ✓ call won +10.77% · α vs SPY +5.22% · entry $54.16 → $60.00
Entry anchored
Apr 21, 03:59 PM ET
via exchange tick
T+1d
-0.72%
call -0.72% · α -0.33%
$53.77
settled 5mo ago
T+5d
-1.71%
call -1.71% · α -1.76%
$53.24
settled 5mo ago
T+20d
-8.04%
call -8.04% · α -11.20%
$49.81
settled 5mo ago
T+60d
+10.77%
call +10.77% · α +5.22%
$60.00
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

BioMarin Pharmaceutical Inc. filed a definitive proxy statement (DEFA14A) for its annual shareholder meeting, which is routine corporate governance documentation.

Key Facts

  • Company filed a definitive proxy statement (DEFA14A) for its annual meeting
  • This is a standard regulatory filing required for shareholder meetings
  • No material financial information or significant corporate actions were disclosed in this filing

Financial Impact

None - this is a routine governance filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001628280-26-026298
Document: 0001628280-26-026298-index-headers.html0001628280-26-026298
Document: 0001628280-26-026298-index.html0001628280-26-026298
Document: 0001628280-26-026298.txt0001628280-26-026298
11 reports for BMRN
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+60▲ +8.91%Apr 27, 2026
Filters
Rows
Reports for BMRN — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
8-K
NEUTRAL ★ 4/10
$64.45 $63.94▼ −0.79%▼ −1.61%$57.70 (−10.47%)
Sep 14, 2026
18d ago
8-K
NEUTRAL ★ 2/10
$66.41 $64.06▼ −3.54%▼ −3.65%$57.70 (−13.12%)
Sep 1, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$64.84 $64.41▼ −0.66%▼ −0.74%$57.70 (−11.01%)
Sep 1, 2026
4w ago
Press Release
NEUTRAL ★ 4/10
$64.84 $64.41▼ −0.66%▼ −0.74%$57.70 (−11.01%)
Aug 31, 2026
4w ago
8-K
BULLISH ★ 6/10
$65.23 $64.63▼ −0.92%▼ −0.78%$57.70 (−11.54%)
Aug 18, 2026
6w ago
8-K
BULLISH ★ 7/10
$66.99 $66.12▼ −1.30%▼ −1.10%$57.70 (−13.87%)
Jun 4, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$56.77 $55.95▼ −1.44%▼ −2.01%$57.70 (+1.64%)
Apr 27, 2026
22w ago
8-K
BULLISH ★ 8/10
$53.62 $55.42▲ +3.36%▲ +2.96%$57.70 (+7.60%)
Apr 21, 2026
23w ago
DEFA14A
NEUTRAL ★ 2/10
$54.16 $53.24▼ −1.71%▼ −1.76%$57.70 (+6.53%)
Feb 28, 2026
30w ago
Institutional Cluster
MIXED ★ 6/10
$59.71 $60.65▲ +1.57%▲ +2.78%$57.70 (−3.37%)
Showing 10 of 11

US Market Status

Market Open — Closes in 1h 9m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access